In this work, the inhibitory ability and mechanism of ω3nicotinic acid (ω3-NA) and ω3-Picolinic acid (ω3-PA) complexes on the activity of mushroom tyrosinase (MT) were scrutinized for progressing a novel MT inhibitor. The complexes were synthesized. It was shown to have a considerable inhibition on the MT activity and K i value of ω3-NA and ω3-PA on MT equal to 5.2 and 5.1 mM, respectively. ω3-NA and ω3-PA inhibited MT with V max values in the range of 0.134 mM and 0.14 mM, respectively. The outputs obtained from fluorescence quenching specified that ω3-NA and ω3-PA could interact with MT.Especially, the decrease in fluorescence intensity was due to the formation of a ligand-enzyme complex which was mostly motivated by hydrogen bonding and hydrophobic forces. The presence of ω3-NA and ω3-PA altered the structure of MT and reduced the α-helix of the enzyme. Molecular docking investigation along with molecular dynamics simulation exhibited that ligands-MT formation is directed by hydrogen binding with Trp136, His263, and Val299 residues. The results highlight that ω3-NA and ω3-PA can be considered as possible inhibitors in treating hyperpigmentation via MT enzyme inhibition.
Results and DiscussionAnalysis of complexes synthesized by NMR Synthesis confirmation and characterization were performed using NMR. 13 C spectra were taken from the synthesized compounds. The 1 H and 13 C NMR ω3-NA showed the shifting 14.1 (CH 3 ), 21.2 (2CH 2 ), 22.8 (CH 2 ), 26.1 (3CH 2 ), 30 (CH 2 ), 31